Authors:
MESSICK CR
MAMDANI M
MCNICHOLL IR
DANZIGER LH
RODVOLD KA
CONDON RE
WALKER AP
EDMISTON CE
Citation: Cr. Messick et al., PHARMACOECONOMIC ANALYSIS OF AMPICILLIN-SULBACTAM VERSUS CEFOXITIN INTHE TREATMENT OF INTRAABDOMINAL INFECTIONS, Pharmacotherapy, 18(1), 1998, pp. 175-183
Authors:
CHUCK SK
KILLIAN AD
LUER M
DANZIGER LH
RODVOLD KA
Citation: Sk. Chuck et al., PENETRATION OF VANCOMYCIN (V) INTO CEREBROSPINAL-FLUID (CSF) OF VENTRICULOSTOMY PATIENTS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 41-41
Authors:
GOTFRIED MH
KILLIAN AD
SERVI RJ
DANZIGER LH
RODVOLD KA
Citation: Mh. Gotfried et al., IV CEFUROXIME PLUS ORAL CLARITHROMYCIN OR IV ERYTHROMYCIN FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN HOSPITALIZED-PATIENTS - A PILOT-STUDY, Clinical drug investigation, 14(1), 1997, pp. 23-34
Authors:
MARTIN SJ
PENDLAND SL
CHEN C
SCHRECKENBERGER PC
DANZIGER LH
Citation: Sj. Martin et al., IN-VITRO ACTIVITY OF CLARITHROMYCIN ALONE AND IN COMBINATION WITH CIPROFLOXACIN OR LEVOFLOXACIN AGAINST LEGIONELLA SPP - ENHANCED EFFECT BYTHE ADDITION OF THE METABOLITE 14-HYDROXY CLARITHROMYCIN, Diagnostic microbiology and infectious disease, 29(3), 1997, pp. 167-171
Authors:
PENDLAND SL
MARTIN SJ
CHEN C
SCHRECKENBERGER PC
DANZIGER LH
Citation: Sl. Pendland et al., COMPARISON OF CHARCOAL-BASED AND STARCH-BASED MEDIA FOR TESTING SUSCEPTIBILITIES OF LEGIONELLA SPECIES TO MACROLIDES, AZALIDES, AND FLUOROQUINOLONES, Journal of clinical microbiology, 35(11), 1997, pp. 3004-3006
Citation: Jm. Meyer et al., IN-VITRO SYNERGY TESTING OF CLARITHROMYCIN AND 14-HYDROXYCLARITHROMYCIN WITH AMOXICILLIN OR BISMUTH SUBSALICYLATE AGAINST HELICOBACTER-PYLORI, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1607-1608
Authors:
RODVOLD KA
GOTFRIED MH
DANZIGER LH
SERVI RJ
Citation: Ka. Rodvold et al., INTRAPULMONARY STEADY-STATE CONCENTRATIONS OF CLARITHROMYCIN AND AZITHROMYCIN IN HEALTHY ADULT VOLUNTEERS, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1399-1402
Authors:
KANYOK TP
KILLIAN AD
RODVOLD KA
DANZIGER LH
Citation: Tp. Kanyok et al., PHARMACOKINETICS OF INTRAMUSCULARLY ADMINISTERED AMINOSIDINE IN HEALTHY-SUBJECTS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 982-986
Authors:
OCCHIPINTI DJ
PENDLAND SL
SCHOONOVER LL
RYPINS EB
DANZIGER LH
RODVOLD KA
Citation: Dj. Occhipinti et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 MULTIPLE-DOSE PIPERACILLIN-TAZOBACTAM REGIMENS, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2511-2517
Authors:
MEYER JM
RYU S
PENDLAND SL
KANYOK TP
DANZIGER LH
Citation: Jm. Meyer et al., IN-VITRO SYNERGY TESTING OF AMINOSIDINE (AMS) WITH METRONIDAZOLE ALONE (M) OR METRONIDAZOLE PLUS HYDROXYMETRONIDAZOLE (HM) AGAINST HELICOBACTER-PYLORI, Gastroenterology, 112(4), 1997, pp. 1041-1041
Authors:
MARTIN SJ
PENDLAND SL
CHEN C
SCHRECKENBERGER P
DANZIGER LH
Citation: Sj. Martin et al., IN-VITRO SYNERGY TESTING OF MACROLIDE QUINOLONE COMBINATIONS AGAINST 41 CLINICAL ISOLATES OF LEGIONELLA, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1419-1421
Citation: Lh. Danziger et Sl. Pendland, BACTERIAL-RESISTANCE TO BETA-LACTAM ANTIBIOTICS, American journal of health-system pharmacy, 52(6), 1995, pp. 3-8
Authors:
SCHOONOVER L
OCCHIPINTI DJ
RODVOLD KA
DANZIGER LH
Citation: L. Schoonover et al., PIPERACILLIN TAZOBACTAM - A NEW BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATION/, The Annals of pharmacotherapy, 29(5), 1995, pp. 501-514
Citation: Dn. Fish et al., DEVELOPMENT OF RESISTANCE DURING ANTIMICROBIAL THERAPY - A REVIEW OF ANTIBIOTIC CLASSES AND PATIENT CHARACTERISTICS IN 173 STUDIES, Pharmacotherapy, 15(3), 1995, pp. 279-291
Authors:
OCCHIPINTI DJ
CHOI A
DEYO K
DANZIGER LH
FISCHER JH
Citation: Dj. Occhipinti et al., INFLUENCE OF RIFAMPIN AND CLARITHROMYCIN ON DAPSONE (D) DISPOSITION AND METHEMOGLOBIN CONCENTRATIONS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 163-163
Authors:
DANZIGER LH
PISCITELLI SC
OCCHINTI DJ
RESNICK DJ
RODVOLD KA
Citation: Lh. Danziger et al., STEADY-STATE PHARMACOKINETICS OF CEFOPERAZONE AND SULBACTAM IN PATIENTS WITH ACUTE APPENDICITIS, The Annals of pharmacotherapy, 28(6), 1994, pp. 703-707
Authors:
OCCHIPINTI DJ
GUBBINS PO
SCHRECKENBERGER P
DANZIGER LH
Citation: Dj. Occhipinti et al., FREQUENCY, PATHOGENICITY AND MICROBIOLOGIC OUTCOME OF NON-CANDIDA ALBICANS CANDIDURIA, European journal of clinical microbiology & infectious diseases, 13(6), 1994, pp. 459-467
Citation: Tp. Kanyok et al., ACTIVITY OF AMINOSIDINE (PAROMOMYCIN) FOR MYCOBACTERIUM-TUBERCULOSIS AND MYCOBACTERIUM-AVIUM, Journal of antimicrobial chemotherapy, 33(2), 1994, pp. 323-327
Citation: Lh. Danziger et al., CENTRAL-NERVOUS-SYSTEM TOXICITY ASSOCIATED WITH MEPERIDINE USE IN HEPATIC-DISEASE, Pharmacotherapy, 14(2), 1994, pp. 235-238
Citation: Sj. Martin et Lh. Danziger, CONTINUOUS-INFUSION OF LOOP DIURETICS IN THE CRITICALLY ILL - A REVIEW OF THE LITERATURE, Critical care medicine, 22(8), 1994, pp. 1323-1329
Authors:
PENDLAND SL
PISCITELLI SC
SCHRECKENBERGER PC
DANZIGER LH
Citation: Sl. Pendland et al., IN-VITRO ACTIVITIES OF METRONIDAZOLE AND ITS HYDROXY METABOLITE AGAINST BACTEROIDES SPP, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2106-2110
Authors:
FISH DN
GOTFRIED MH
DANZIGER LH
RODVOLD KA
Citation: Dn. Fish et al., PENETRATION OF CLOARITHROMYCIN INTO LUNG TISSUES FROM PATIENTS UNDERGOING LUNG RESECTION, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 876-878